Aegerion planning follow-on

Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) said late Thursday it is planning a follow-on underwritten by Jefferies and JPMorgan. This month, Aegerion plans to launch its homozygous familial hyperchol...